{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:44:42Z","timestamp":1791380682115,"version":"4.3.3"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jns.2017.01.012","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T05:28:09Z","timestamp":1483680489000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"special_numbering":"C","title":["Dementia in Parkinson's disease"],"prefix":"10.1016","volume":"374","author":[{"given":"Hasmet A.","family":"Hanagasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Tufekcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Emre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jns.2017.01.012_bb0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson's disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2017.01.012_bb0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.jns.2017.01.012_bb0015","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.parkreldis.2015.08.024","article-title":"Mild Cognitive Impairment in newly diagnosed Parkinson's disease: a longitudinal prospective study","volume":"21","author":"Santangelo","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"15","key":"10.1016\/j.jns.2017.01.012_bb0020","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1212\/WNL.0000000000002001","article-title":"Longitudinal study of normal cognition in Parkinson disease","volume":"85","author":"Pigott","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2017.01.012_bb0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.20324","article-title":"Sydney Multicenter Study of Parkinson's disease: non-l-dopa-responsive problems dominate at 15years","volume":"20","author":"Hely","year":"2005","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2017.01.012_bb0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2017.01.012_bb0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.10219","article-title":"Combined effect of age and severity on the risk of dementia in Parkinson's disease","volume":"51","author":"Levy","year":"2002","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2017.01.012_bb0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00415-008-0629-9","article-title":"Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?","volume":"255","author":"Marion","year":"2008","journal-title":"J. Neurol."},{"issue":"14","key":"10.1016\/j.jns.2017.01.012_bb0045","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0000000000000842","article-title":"Predictors of dementia in Parkinson disease: a prospective cohort study","volume":"83","author":"Anang","year":"2014","journal-title":"Neurology"},{"issue":"Pt 11","key":"10.1016\/j.jns.2017.01.012_bb0050","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson's disease: 5year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jns.2017.01.012_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WAD.0b013e3181d71a13","article-title":"Influence of white matter hyperintensities on the cognition of patients with Parkinson disease","volume":"24","author":"Lee","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.jns.2017.01.012_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.parkreldis.2015.12.017","article-title":"Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease","volume":"24","author":"Ham","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.01.012_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.archger.2015.10.006","article-title":"The cross-sectional and longitudinal relationships between white matter hyperintensities and dementia in patients with Parkinson's disease: a retrospective analysis of 132 patients in a single center","volume":"62","author":"Lee","year":"2016","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"11","key":"10.1016\/j.jns.2017.01.012_bb0070","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.parkreldis.2014.08.024","article-title":"Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease","volume":"20","author":"Kandiah","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2017.01.012_bb0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-150610","article-title":"Vascular risk factors and cognition in Parkinson's disease","volume":"51","author":"Pilotto","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2017.01.012_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26698","article-title":"Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease","author":"Malek","year":"2016","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2017.01.012_bb0085","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.jns.2017.01.012_bb0090","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1212\/01.WNL.0000130159.28215.6A","article-title":"APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease","volume":"62","author":"Huang","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2017.01.012_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.21192","article-title":"Tau and alpha-synuclein in susceptibility to, and dementia in Parkinson's disease","volume":"62","author":"Goris","year":"2007","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2017.01.012_bb0100","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/jnnp.2003.026203","article-title":"Tau gene and Parkinson's disease: a case-control study and meta-analysis","volume":"75","author":"Healy","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 2","key":"10.1016\/j.jns.2017.01.012_bb0105","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/brain\/aws318","article-title":"Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort","volume":"136","author":"Winder-Rhodes","year":"2013","journal-title":"Brain"},{"issue":"Pt 8","key":"10.1016\/j.jns.2017.01.012_bb0110","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/brain\/awu143","article-title":"Visual short-term memory deficits associated with GBA mutation and Parkinson's disease","volume":"137","author":"Zokaei","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.01.012_bb0115","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.2245","article-title":"Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease","author":"Davis","year":"2016","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.jns.2017.01.012_bb0120","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications","volume":"55","author":"Farrer","year":"2004","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2017.01.012_bb0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.parkreldis.2009.09.008","article-title":"alpha-Synuclein multiplication analysis in Italian familial Parkinson disease","volume":"16","author":"Sironi","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2017.01.012_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamaneurol.2013.4498","article-title":"Cognitive and motor function in long-duration PARKIN-associated Parkinson disease","volume":"71","author":"Alcalay","year":"2014","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.jns.2017.01.012_bb0135","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1533317512460562","article-title":"Cognitive profile of the earliest stage of dementia in Parkinson's disease","volume":"27","author":"Petrova","year":"2012","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"issue":"5","key":"10.1016\/j.jns.2017.01.012_bb0140","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/mds.25426","article-title":"Measuring mild cognitive impairment in patients with Parkinson's disease","volume":"28","author":"Marras","year":"2013","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2017.01.012_bb0145","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/WNL.0b013e31829c5c86","article-title":"Evolution of mild cognitive impairment in Parkinson disease","volume":"81","author":"Broeders","year":"2013","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.jns.2017.01.012_bb0150","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/mds.25655","article-title":"Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease","volume":"28","author":"Goldman","year":"2013","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jns.2017.01.012_bb0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/ane.12189","article-title":"Cognitive impairment in early-stage non-demented Parkinson's disease patients","volume":"129","author":"Pfeiffer","year":"2014","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.jns.2017.01.012_bb0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","article-title":"Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study","volume":"82","author":"Yarnall","year":"2014","journal-title":"Neurology"},{"issue":"3\u20134","key":"10.1016\/j.jns.2017.01.012_bb0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000433421","article-title":"Mild cognitive impairment in early Parkinson's disease using the Movement Disorder Society Task Force Criteria: cross-sectional study in Hoehn and Yahr stage 1","volume":"40","author":"Stefanova","year":"2015","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"2","key":"10.1016\/j.jns.2017.01.012_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/WAD.0000000000000088","article-title":"Onset of mild cognitive impairment in Parkinson disease","volume":"30","author":"Johnson","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1","key":"10.1016\/j.jns.2017.01.012_bb0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mds.10633","article-title":"Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia","volume":"19","author":"Noe","year":"2004","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2017.01.012_bb0180","first-page":"195","article-title":"Evidence for impaired encoding and retrieval memory profiles in Parkinson disease","volume":"17","author":"Weintraub","year":"2004","journal-title":"Cogn. Behav. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2017.01.012_bb0185","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1212\/01.WNL.0000145764.70698.4E","article-title":"Visual perception in Parkinson disease dementia and dementia with Lewy bodies","volume":"63","author":"Mosimann","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2017.01.012_bb0190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.2005.083113","article-title":"Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress","volume":"78","author":"Aarsland","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2017.01.012_bb0195","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/mds.21864","article-title":"A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia","volume":"23","author":"Pagonabarraga","year":"2008","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.jns.2017.01.012_bb0200","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/mds.26632","article-title":"Orthostatic hypotension and cognitive impairment in Parkinson's disease: causation or association?","volume":"31","author":"McDonald","year":"2016","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.jns.2017.01.012_bb0205","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.2006.102343","article-title":"Autonomic dysfunction in dementia","volume":"78","author":"Allan","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.jns.2017.01.012_bb0210","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/mds.10565","article-title":"What causes mental dysfunction in Parkinson's disease?","volume":"18","author":"Emre","year":"2003","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.jns.2017.01.012_bb0215","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.parkreldis.2013.05.010","article-title":"Neuropathology of dementia in a large cohort of patients with Parkinson's disease","volume":"19","author":"Horvath","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2017.01.012_bb0220","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Ann. Neurol."},{"issue":"Pt 10","key":"10.1016\/j.jns.2017.01.012_bb0225","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/brain\/aws234","article-title":"Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies","volume":"135","author":"Schneider","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jns.2017.01.012_bb0230","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","article-title":"Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease","volume":"129","author":"Liu","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2017.01.012_bb0235","first-page":"185","article-title":"Morphological substrates of mental dysfunction in Lewy body disease: an update","volume":"59","author":"Jellinger","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"issue":"3","key":"10.1016\/j.jns.2017.01.012_bb0240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"issue":"6","key":"10.1016\/j.jns.2017.01.012_bb0245","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mds.22799","article-title":"Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia","volume":"25","author":"Apostolova","year":"2010","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.jns.2017.01.012_bb0250","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.parkreldis.2015.06.013","article-title":"Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia","volume":"21","author":"Borroni","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2017.01.012_bb0255","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1148\/radiol.12111280","article-title":"Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging","volume":"263","author":"Seibert","year":"2012","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.jns.2017.01.012_bb0260","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/gps.4342","article-title":"Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences","volume":"30","author":"Peraza","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2017.01.012_bb0265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mds.26312","article-title":"Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson's disease?","volume":"31","author":"Duncan","year":"2016","journal-title":"Mov. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2017.01.012_bb0270","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S1353-8020(11)70031-1","article-title":"PET studies in Parkinson's disease motor and cognitive dysfunction","volume":"18","author":"Pavese","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"11","key":"10.1016\/j.jns.2017.01.012_bb0275","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2017.01.012_bb0280","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroimage.2007.09.072","article-title":"[11C]PIB binding in Parkinson's disease dementia","volume":"39","author":"Maetzler","year":"2008","journal-title":"NeuroImage"},{"issue":"12","key":"10.1016\/j.jns.2017.01.012_bb0285","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","article-title":"Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography","volume":"79","author":"Edison","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.jns.2017.01.012_bb0290","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.parkreldis.2015.04.027","article-title":"Amyloid-\u03b2 and \u03b1-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease","volume":"21","author":"Stav","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"10","key":"10.1016\/j.jns.2017.01.012_bb0295","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","article-title":"Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease","volume":"72","author":"B\u00e4ckstr\u00f6m","year":"2015","journal-title":"JAMA Neurol."},{"issue":"Pt 9","key":"10.1016\/j.jns.2017.01.012_bb0300","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/brain\/awv181","article-title":"Cerebrospinal fluid tau and amyloid-\u03b21-42 in patients with dementia","volume":"138","author":"Skillb\u00e4ck","year":"2015","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jns.2017.01.012_bb0305","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","article-title":"Cerebrospinal fluid \u03b1-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort","volume":"184","author":"Stewart","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"Pt 4","key":"10.1016\/j.jns.2017.01.012_bb0310","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/brain\/aww018","article-title":"Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease","volume":"139","author":"Latreille","year":"2016","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jns.2017.01.012_bb0315","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"issue":"16","key":"10.1016\/j.jns.2017.01.012_bb0320","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","article-title":"Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force","volume":"22","author":"Dubois","year":"2007","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2017.01.012_bb0325","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"issue":"Suppl. 3","key":"10.1016\/j.jns.2017.01.012_bb0330","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop","volume":"9","author":"McKeith","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.jns.2017.01.012_bb0335","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1017\/S1041610208008612","article-title":"Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity","volume":"21","author":"Aarsland","year":"2009","journal-title":"Int. Psychogeriatr."},{"issue":"11","key":"10.1016\/j.jns.2017.01.012_bb0340","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","article-title":"DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers","volume":"68","author":"Lippa","year":"2007","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2017.01.012_bb0345","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.parkreldis.2003.12.005","article-title":"Dementia with Lewy bodies and Parkinson's disease","volume":"10","author":"McKeith","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2017.01.012_bb0350","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/jnnp.2007.134163","article-title":"Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide","volume":"7","author":"McKeith","year":"2007","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jns.2017.01.012_bb0355","doi-asserted-by":"crossref","DOI":"10.1093\/jnen\/nlw070","article-title":"Distribution and load of amyloid-\u03b2 pathology in Parkinson disease and dementia with Lewy bodies","author":"Hepp","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2017.01.012_bb0360","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jagp.2013.03.001","article-title":"Amiloid PET imaging in Lewy body disorders","volume":"23","author":"Donaghy","year":"2015","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"8","key":"10.1016\/j.jns.2017.01.012_bb0365","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1212\/01.wnl.0000269666.62598.1c","article-title":"Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies","volume":"69","author":"Beyer","year":"2007","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2017.01.012_bb0370","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2017.01.012_bb0375","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.26236","article-title":"Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study","volume":"30","author":"Mamikonyan","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2017.01.012_bb0380","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp.2008.144048","article-title":"A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease","volume":"80","author":"Grace","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"24","key":"10.1016\/j.jns.2017.01.012_bb0385","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jns.2017.01.012_bb0390","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/mds.20700","article-title":"Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study","volume":"21","author":"Poewe","year":"2006","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.jns.2017.01.012_bb0395","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000184517.69816.e9","article-title":"Benefits of rivastigmine on attention in dementia associated with Parkinson disease","volume":"65","author":"Wesnes","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2017.01.012_bb0400","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","article-title":"Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis","volume":"86","author":"Wang","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.jns.2017.01.012_bb0405","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","volume":"8","author":"Aarsland","year":"2009","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.jns.2017.01.012_bb0410","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jns.2017.01.012_bb0415","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T21:13:30Z","timestamp":1658351610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1730014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":83,"alternative-id":["S0022510X1730014X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.01.012","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dementia in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}